HUT54412A - Process for producing retrovirus proteaze, reverze transkriptaze and endonucleaze enzymes - Google Patents

Process for producing retrovirus proteaze, reverze transkriptaze and endonucleaze enzymes

Info

Publication number
HUT54412A
HUT54412A HU896176A HU617689A HUT54412A HU T54412 A HUT54412 A HU T54412A HU 896176 A HU896176 A HU 896176A HU 617689 A HU617689 A HU 617689A HU T54412 A HUT54412 A HU T54412A
Authority
HU
Hungary
Prior art keywords
retroviral
proteins
transkriptaze
reverze
proteaze
Prior art date
Application number
HU896176A
Other languages
English (en)
Other versions
HU896176D0 (en
HU209835B (en
Inventor
Atsusi Saito
Hideo Shinagawa
Atsuo Nakata
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1088411A external-priority patent/JP2852431B2/ja
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of HU896176D0 publication Critical patent/HU896176D0/hu
Publication of HUT54412A publication Critical patent/HUT54412A/hu
Publication of HU209835B publication Critical patent/HU209835B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU896176A 1988-12-07 1989-11-24 Method for producing of retrovirus protease, reverse transcriptase and integrase HU209835B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30942788 1988-12-07
JP1088411A JP2852431B2 (ja) 1988-12-07 1989-04-06 レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法

Publications (3)

Publication Number Publication Date
HU896176D0 HU896176D0 (en) 1990-02-28
HUT54412A true HUT54412A (en) 1991-02-28
HU209835B HU209835B (en) 1994-11-28

Family

ID=26429797

Family Applications (1)

Application Number Title Priority Date Filing Date
HU896176A HU209835B (en) 1988-12-07 1989-11-24 Method for producing of retrovirus protease, reverse transcriptase and integrase

Country Status (9)

Country Link
EP (1) EP0372904B1 (hu)
AT (1) ATE112318T1 (hu)
AU (1) AU643942B2 (hu)
CA (1) CA2004646C (hu)
DE (1) DE68918563T2 (hu)
DK (1) DK612889A (hu)
HU (1) HU209835B (hu)
MY (1) MY104975A (hu)
NZ (1) NZ231593A (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0867510A1 (en) * 1990-05-28 1998-09-30 The Research Foundation For Microbial Diseases Of Osaka University Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof
WO1992011028A1 (en) * 1990-12-19 1992-07-09 Epitope, Inc. Hiv reverse transcriptase vaccine
EP0555797A1 (en) * 1992-02-10 1993-08-18 Becton, Dickinson and Company General buffer for restriction endonucleases
EP0805873B1 (en) * 1995-01-27 1999-09-01 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Methods for sensitive detection of reverse transcriptase
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
RO118887B1 (ro) * 1996-01-29 2003-12-30 Virologic, Inc. Metodă pentru determinarea sensibilităţii sau eficacităţii biologice şi rezistenţei omului la medicamentele antivirale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7512287A (en) * 1986-05-20 1987-12-22 Dana-Farber Cancer Institute Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof

Also Published As

Publication number Publication date
NZ231593A (en) 1992-07-28
DE68918563T2 (de) 1995-02-23
MY104975A (en) 1994-07-30
ATE112318T1 (de) 1994-10-15
EP0372904A2 (en) 1990-06-13
EP0372904B1 (en) 1994-09-28
HU896176D0 (en) 1990-02-28
DE68918563D1 (de) 1994-11-03
CA2004646C (en) 1999-10-05
EP0372904A3 (en) 1991-09-25
HU209835B (en) 1994-11-28
AU4590889A (en) 1990-08-02
DK612889A (da) 1990-06-08
DK612889D0 (da) 1989-12-05
CA2004646A1 (en) 1990-06-07
AU643942B2 (en) 1993-12-02

Similar Documents

Publication Publication Date Title
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
FI832825A (fi) Jaesthybridvektorer och deras anvaendning foer framstaellning av polypeptider
FI881185A (fi) Human mangan-superoxiddismutas (hmn-sod).
UA19765A (uk) Фрагмеhт hуклеїhової кислоти, що кодує людський проаполіпопротеїн а-1
IT1156461B (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
DK0495896T3 (da) Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel
ES2058566T3 (es) Sondas de hibridacion para detectar las cepas de neisseria.
DE69132681D1 (de) Klonierung und Expression von Borrelia Lipoproteinen
EP0485611A4 (en) Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
CA2341946A1 (fr) Polypeptides et compositions prepares a partir de l'amplification de genome des retrovirus du type hiv-2 et siv
HU906046D0 (en) Process for producing protein having urate-oxidase activity, gene coding that, vector of exprossion, micro organisms and transformed cells
HUT54412A (en) Process for producing retrovirus proteaze, reverze transkriptaze and endonucleaze enzymes
HUP9802915A2 (hu) Új sztafilokinázszármazékok
Saito et al. Protease, reverse transcriptase and endonuclease of HIV-1 and RSV method for producing these enzymes
TH9629EX (th) โพรเทเอส, รีเวอร์ส แทรนส์คริพเทส และเอนโดนิวคลี เอสของ ของเรโทรไวรัส และวิธีการสำหรับผลิตเอนไซม์เหล่า นี้
TH9629A (hu)
JPS6485092A (en) Production of protein
TH21549A (th) ลำดับเบสของยีนโปรตีนหุ้มห่อของไวรัสโรคใบลายและผิดรูปของมะละกอ
ES2005189A6 (en) Nucleotide sequences from RESA antigen of Plasmodium falciparum

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee